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Compartmentalized, multiphasic nanocolloids
with potential applications in drug delivery and
biomedical imaging
K.-H. Roh1, M. Yoshida2, J. Lahann1-3
Nanoparticles are excellent candidates for drug delivery or bio-
medical imaging, because they often exhibit superb tuneability of
critical properties, such as size, surface characteristics, degradation
rate, and therefore drug release rates. We have recently developed a
route towards fabrication of sub-micron particles that relies on elec-
trohydrodynamic co-jetting. In this process, fluid manipulation in
an electrical field is used to fabricate large quantities of multi-com-
partment particles, where individual compartments can be indepen-
dently loaded with different drugs or selectively surface-modified.
In this contribution, aspects of multifunctional particles for biome-
dical applications are reviewed and a specific focus is given to re-
cent progress with compartmentalized, multiphasic nanocolloids in
our laboratory.
Keywords: Electrified jetting; electrospinning; nanoparticle; na-
nocolloid; multifunctional; drug delivery; biomedical imaging.
1 Introduction
Nanoparticles carry potential for use in drug delivery or as
imaging probes because of their controllable sizes, surface
characteristics, and degradation rates. By simply changing
materials and formulation processes, a wide variety of char-
acteristics can be achieved [1–7]. This has allowed for the use
of nanoparticles in a wide variety of biomedical applications
ranging from drug delivery to blood pool imaging. Nanopar-
ticles have been proposed as circulating reservoirs for drugs
that are associated with short circulation times (e.g. proteins
and peptides) and targeted to specific tissues to minimize dose
and toxic side effects [8–11]. As such, clearance of nanopar-
ticles by macrophages and Kupffer cells of the liver upon in-
troduction into the circulation poses a limitation to effective
use of nanoparticles in medicine [12]. Efforts to render par-
ticles less prone to clearance and improve long-circulation
properties include particle surface modifications as well as ad-
sorption of particles to circulating erythrocytes [13–15].
While passive targeting strategies take advantage of patho-
physiological or anatomical properties of the human body, ac-
tive strategies involve selective affinity of the drug construct
to recognize a specific cell, tissue, or organ. In this approach, a
targeting moiety, such as an antibody, a peptide, a ligand, or an
aptamer, is conjugated with the drug itself or with a nanosys-
tem loaded with the therapeutic agent.
The vision that nanoparticles could essentially act as func-
tional components in novel device generations, which “magi-
cally” maneuver themselves within the human body, has re-
sulted in a new euphoria in nanomedicine. This vision has al-
ready fueled significant advances in the synthesis of a multi-
tude of nano-objects with different properties, compositions,
and structures, majority of which is still compositionally
homogeneous. Nevertheless, multi-phasic nanosystems
seemmore feasible than ever [16]. To date, several approaches
for the preparation of Janus particles using microcontact print-
ing, partial masking, microfluidic co-flow, and selective de-
position have been reported [17–23]. In such nanomaterials,
the anisotropic distribution of the two or more different che-
mical species becomes another governing rule.Wework under
the premise, that a nanosystem is a material with unique prop-
erties that has subcellular dimensions and sizes below 1000
nm, such as polymer-based nanoparticles and nanocolloids,
liposomes, polysomes, micelles, or dendrimer-drug conju-
gates [24].
While effect of size, surface chemistry, and polymer com-
position on particle behavior has been studied in great detail, it
is only recently that fabrication methods for non-spherical
particles has enabled study of role of particle shape in appli-
cations including drug delivery [25]. Using particles of var-
ious shapes and aspect ratios, it was shown that the fate of
particles with respect to phagocytosis was determined by
the local shape at the point of contact between the phagocyte
and the particles [26]. With increased command of fabrication
methods to control various particle parameters and their fate
in vivo, production of highly tailored systems via combination
of these approaches becomes possible, and presents a unique
opportunity for drug delivery.
In the following discussion, we will describe aspects of
compartmentalized, multiphasic nanocolloids in our labora-
tory recently published in a series of journals [27–30].
2 Preparation and characterization of
biphasic nanocolloids
Our approach towards biphasic nanocolloids differs funda-
mentally from the previously introduced methods in that it
takes advantage of polymer solutions, specifically solutions
of FDA-approved polymers. Using electrified polymer jets
to create an anisotropic materials distribution in nanoparticles,
we have developed an approach towards biphasic nanocarriers
that was termed “electrohydrodynamic co-jetting” or “electri-
fied co-jetting”. Electrified jetting is a process to generate li-
quid jets by use of electrostatic forces [31]. Electrohydrody-
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namics has already resulted in isotropic materials made from
single-phase polymer solutions, blends, and hybrid materials,
as well as coaxial fibers and core/shell particles [32–38]. Na-
nofibers have been suggested for various biomedical applica-
tions such as for scaffolds in tissue engineering [39–41], con-
trolled drug delivery systems [42] and enzyme-carrying bio-
catalyst [43]. Similarly, dual piezoelectric ejection system has
been developed to produce core-shell microcapsules by taking
advantage of interfacial phase separation [44].
Thus far, first promising biphasic nanocolloids have been
identified using computational simulations and first proto-
types of biphasic particles have been prepared [27]. In that
initial work, side-by-side dual jetting capillaries [45, 46]
were utilized to successfully produce a liquid cone and a
jet with an anisotropic material distribution (Figure 1).
With practical applications in biomedical field in mind,
two jetting solutions were designed to be made of a mixture
of poly(acrylic acid) (PAA) and poly(acrylic amide)-co-ac-
rylic acid (PAAm-co-AA) with varying concentrations of
fluorescence-labeled macromolecules [28]. Upon establishing
appropriate ratios of PAA and PAAm-co-AA, nanocolloids
were prepared, and then exposed to elevated temperatures
to induce crosslinking. This thermal imidization was moni-
tored by Fourier Transform Infrared (FTIR) Spectroscopy
for various reaction conditions, and was found to profoundly
enhance the stability of the biphasic nanocarriers in aqueous
environment. While the polymer system employed herein
takes advantage of commercially available polymers which
are amenable to thermal crosslinking, this stabilization meth-
od may not be appropriate in cases where the particles are
loaded with drugs, especially proteins and enzymes, or
with other molecules that may be fragile at elevated tempera-
tures. In such instances, polymeric systems with UV-cross-
linkable moieties and appropriate initiators may be employed
for photo-initiated stabilization.
Figure 2a shows a series of FTIR spectra of nanocolloids
prepared using polymer composition of 5% of PAAm-co-AA
with 1% of PAA. All the samples were directly jetted onto a
piece of gold substrate and FTIR reflectance measured after
each reaction time at 175oC. After 60 min, the characteristic
C=O stretching band (amide I around 1673 cm-1) and the C-
NH band of amide group (amide II around 1673 cm-1) de-
creased, while bands characteristic for imide groups appeared
near 1720 cm-1 and 1221 cm-1. Figure 2b shows the confocal
laser scanning microscope images of biphasic nanocolloids
suspended in a phosphate buffered saline (PBS) after thermal
imidization. These images confirm the effectiveness of ther-
mal reaction at 175oC for 60 min to stabilize the biphasic na-
nocolloids. In addition, as observed from individual phases
and the overlay of the two phases, the fluorescence-labeled
dextrans incorporated in each phase showed little interfacial
diffusion or mixing after thermal reaction, even after storage
in water for several weeks. Moreover, biphasic nanocolloids
composed of 5% PAAm-co-AA and 0.5% of PAA suspended
in PBS maintained their biphasic characteristic during the 2-
week observation period used in this study.
In biomedical applications, biocompatibility of these nano-
colloids is of importance. Preliminary biocompatibility of bi-
phasic nanocarriers composed of PAA and PAAm was eval-
uated using Human Umbilical Vein Endothelial Cells (HU-
VECs) as a model system. Confluent cells in cultured in se-
rum-containing media were exposed to biphasic nanocarriers
for indicated duration and cell viability assessed by trypan
blue exclusion [29]. While this polymer system was not bio-
degradable, the resulting biphasic nanocolloids did not cause
significant cell death, as determined by trypan blue exclusion,
for up to 48 hrs after addition of up to 1mg/ml biphasic na-
nocarrier suspension (Figure 3). Further studies are underway
to more thoroughly investigate the effect of biphasic nanocol-
loids on cells.
3 Preparation and characterization of
triphasic nanocolloids
In a recent advancement, we have succeeded in preparation
and initial characterization of triphasic nanocolloids [30].
Using the same co-jetting approach as described above, simul-
taneous jetting of three distinct polymer solutions was
achieved with a modified nozzle with side-by-side geometry,
Figure 1. Schematic description of
the electrified co-jetting process
used for the preparation of multi-
compartment nanocolloids. (taken
from Roh et al. Nature Materials
2005 [27])
Figure 2. Stabilization of biphasic PAAm nanoparticles. a. FTIR
spectra of biphasic nanocarriers before (blue) and after (green
and red, 1 hour and 12 hours of reation respectively) thermal imi-
dization; b. confocal images of particles stored and imaged in water,
variable magnification, particles are between 100 and several 1000
nm. (taken from Roh et al. Langmuir 2007 [28])
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as shown in Figure 4a. These nanocarriers provide three in-
dependent surfaces and three compartments for potential drug
loading. Figure 4b shows an image of the outlet region during
the jetting process, which consists of three flows (applied
electric potential is approximately 15 kV).
The green, red, and blue jetting solutions are composed of
poly(ethylene oxide) (PEO, MW 600 kD) mixed with diffe-
rent macromolecular dyes: fluorescein-conjugated dextran
(green), rhodamine B-conjugated dextran (red), and Alexa
FluorJ 647-conjugated bovine serum albumin (blue). As
can be observed from Figures 3b and its enlargement (Figure
4c), separation in the three phases is maintained throughout
the pendant droplet. Moreover, these digital images reveal
a single liquid thread maintaining the interface amongst the
three phases.
These triphasic nanocolloids were characterized by confo-
cal laser scanning microscopy (Figure 5a). As shown in the
overlay of the three confocal images (Figure 5a), fluorescent-
labeled macromolecular dyes loaded in each jetting liquid re-
mained compartmentalized to form three separate phases.
Although a range of different nanocolloidal architectures
and interfaces co-existed, the triangular geometry of the mul-
ti-phasic nanocolloids shown in Figure 5 appeared to be pre-
dominant. In addition, scanning electron microscopy (SEM)
studies of PEO-based nanocolloids revealed that these parti-
cles were linked by fine polymer threads with a diameter of
the order of ten nanometers (beads-on-a-string morphology)
(Figure 5b). Based on the SEM analysis, the average diameter
of the beads was determined to be approximately 730 nm with
a standard deviation of 260 nm.
In principle, jetting of polymer solutions under the influ-
ence of electrohydrodynamic forces can be applied to a
wide range of commodity polymers. In addition to the
PEO-based system, electrified co-jetting of either PAA
(MW 250 kD) or PAAm-co-AA (MW 200 kD, 10% acrylic
acid residues) solutions also produced triphasic nanocolloids
. As with the biphasic particles of PAA or PAAm-co-AA, these
particles were thermally crosslinked to stabilize them in aqu-
eous environment. Figures 5c-e show that the fluorescent dyes
were contained within each compartment, and their overlay in
Figure 5f confirms predominance of each dye in only one pha-
se, indicative of tri-compartmental nanocolloids.
Figure 3. Short-term cytotoxicity test of biphasic na-
noparticles. a. Time course and dose-response of bipha-
sic nanoparticles cytotoxicity as measured by HUVEC
viability by trypan blue exclusion; b. Phase contrast mi-
crograph of HUVECs cultured in the presence of
0.1mg/ml biphasic nanocolloids. (Yoshida et al. Bio-
materials 2007, [29])
Figure 4. Production of triphasic nanocarriers. a. Electrified co-
jetting setup used in our experiments with triple side-by-side capil-
laries; b. Actual photograph of the capillary outlet region desig-
nated with dotted line in (a); c. Enlarged photograph of the jet
ejection point designated with dotted line in (b). Scale bars are
500 lm. (taken from Roh et al. JACS 2006, [30])
Figure 5. Confocal laser scanning micrographs and scanning elec-
tron microscopy of PEO- (a and b) and P(AAm-co-AA)-based (c-g)
particles. The individual phases containing biomolecules tagged
with FITC (c), Rhodamine B (d) and Alexa FluorJ 647 (e) and
the overlays of three phases (b and f). (taken from Roh et al. JACS
2006, [30])
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4 Future Outlook
Future advances with the development of increasingly so-
phisticated drug delivery systems as well as with the design of
advanced imaging probes may require the development of na-
noparticles with multiple, independent compartments that can
be independently loaded with different drugs. Electrohydro-
dynamic co-jetting provides a simple, high-throughput fabri-
cation method towards such unique particle geometries and
may play a pivotal role in the design and development of fu-
ture drug delivery and imaging systems. Towards this end, fu-
ture research will need to address how to reduce the often ob-
served polydispersity of particles made by electrified jetting
as well as how to extend this method to other polymer systems
including polymers that can be co-jetted from non-aqueous
solutions and biodegradable polymers.
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